# Rechon Life Science AB - Inspection Records

Source: https://www.keypedia.com/companies/rechon-life-science-ab/ce84eed4-ada6-40a0-9005-2c2d6bbd729d

> Inspection records and compliance data for Rechon Life Science AB in Limhamn, None. Access full analysis and detailed observations.

---

## Details

- Name: Rechon Life Science AB
- FEI Number: 3002806978
- City: Limhamn
- State: None
- Country Name: Sweden
- Address Line 1: Soldattorpsvagen 5
- Zip Code: None

## Related Documents

- [483 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/483/rechon-life-science-ab/d0619c10-f828-42d7-bb95-fbcb3cafc834) — source: FDA, date: September 6, 2024
- [483 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/483/rechon-life-science-ab/36f4eea5-fa8b-4cb8-8f47-b7a20c9ecab9) — source: FDA, date: September 6, 2024
- [483 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/483/rechon-life-science-ab/80f2f448-3fd0-4ebd-a224-a5130b103fc5) — source: FDA, date: September 6, 2024
- [483 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/483/rechon-life-science-ab/ccd7dd5f-15da-4468-8ee0-cf8f066be75d) — source: FDA, date: September 6, 2024
- [483 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/483/rechon-life-science-ab/23e6f4c7-90bc-4c26-9550-fd7a3b364fa7) — source: FDA, date: September 6, 2024
- [WARNING_LETTER - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/warning_letter/rechon-life-science-ab/ec7b8f99-2090-44b2-b048-fe367628faae) — source: FDA, date: September 6, 2024
- [FDA Inspection 1251480 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/87f30167-add4-47fe-ae0d-4a0af25aff58) — source: FDA, date: September 6, 2024
- [FDA Inspection 1251480 - Rechon Life Science AB - 2024-09-06](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/7eaa39d1-9842-4349-8abf-b9462415216b) — classification: Official Action Indicated (OAI), source: FDA, date: September 6, 2024
- [483 - Rechon Life Science AB - 2023-03-17](https://www.keypedia.com/records/483/rechon-life-science-ab/a7301184-4d67-4fbc-b22a-7e0804189aa2) — source: FDA, date: March 17, 2023
- [FDA Inspection 1201600 - Rechon Life Science AB - 2023-03-17](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/3d26d3f2-e239-49fc-bdc7-693e67114bac) — source: FDA, date: March 17, 2023
- [FDA Inspection 1125627 - Rechon Life Science AB - 2019-11-27](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/901cfca6-844e-49de-b6fc-ffadb362df21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 27, 2019
- [FDA Inspection 1060687 - Rechon Life Science AB - 2018-06-29](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/1410a4ff-1c00-409f-b826-3e23ffac83f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 29, 2018
- [FDA Inspection 983550 - Rechon Life Science AB - 2016-06-02](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/121357b8-bdd5-423a-9992-fb040d8d82b3) — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2016
- [FDA Inspection 983550 - Rechon Life Science AB - 2016-06-02](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/95bc7054-4ce1-48a4-8585-7545a2c126e3) — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2016
- [FDA Inspection 969057 - Rechon Life Science AB - 2016-04-29](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/bc113234-3b18-45a7-be62-0c4261c6cf7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2016
- [FDA Inspection 871626 - Rechon Life Science AB - 2014-03-21](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/ae909fd5-febc-448c-97c6-edf43c2920c3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 21, 2014
- [FDA Inspection 748168 - Rechon Life Science AB - 2011-09-16](https://www.keypedia.com/records/fda_inspections/rechon-life-science-ab/94160365-c52f-421c-83d7-0996db8eb99d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2011

## Related Companies

- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Nephron Sc Inc](https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [TOLMAR, Inc.](https://www.keypedia.com/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)

## Related Officers

- [Monica E. Murie](https://www.keypedia.com/people/monica-e-murie/2db840df-d69f-4def-9830-fd461bea5507)
- [Consumer Safety Officer/ Federal Investigator](https://www.keypedia.com/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [investigator](https://www.keypedia.com/people/amir-alavi/d7179128-eb3f-489e-97cf-e2c5e5539a00)